DEEP VEIN THROMBOSIS POSTOPERATIVE

This adverse event was reported 2003 times

These drugs are most commonly taken by patients reporting DEEP VEIN THROMBOSIS POSTOPERATIVE:

# Drug Count
0 DICLOFENAC SODIUM 1494
1 ADALIMUMAB 1472
2 DICLOFENAC 1469
3 ALENDRONATE SODIUM 1428
4 TOCILIZUMAB 1423
5 METHOTREXATE SODIUM 1414
6 FOLIC ACID 1390
7 LEFLUNOMIDE 1375
8 RITUXIMAB 1366
9 METHOTREXATE 1352
See all common drugs associated with DEEP VEIN THROMBOSIS POSTOPERATIVE

DEEP VEIN THROMBOSIS POSTOPERATIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TRICLOSAN 115 0.1993
1 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 100 0.1520
2 CAFFEINE CITRATE 308 0.1320
3 NEOMYCIN OINTMENT 310 0.1264
4 HYDROCORTISONE BUTYRATE 244 0.1235
5 DICLOFENAC POTASSIUM TABLETS 1016 0.1172
6 GOLIMUMAB 1217 0.0966
7 DICLOFENAC POTASSIUM 1016 0.0919
8 CLEAR MINT, GEL TOOTHPASTE 92 0.0839
9 CORTISONE ACETATE 1046 0.0837
See all drugs enriched for association with DEEP VEIN THROMBOSIS POSTOPERATIVE

DEEP VEIN THROMBOSIS POSTOPERATIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 120 0.1744
1 Endoglycosidase [EPC] 239 0.1290
2 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 314 0.0360
3 Provitamin D2 Compound [EPC] 1065 0.0358
4 Interleukin-17A Antagonist [EPC] 1254 0.0336
5 Aminosalicylate [EPC] 1358 0.0135
6 Antirheumatic Agent [EPC] 1375 0.0130
7 Methylxanthine [EPC] 752 0.0129
8 Tetracycline-class Drug [EPC] 898 0.0127
9 Interleukin-6 Receptor Antagonist [EPC] 1503 0.0108
See all drug classes enriched for association with DEEP VEIN THROMBOSIS POSTOPERATIVE